AC
ASMB icon

Armistice Capital’s Assembly Biosciences ASMB Stock Holding History

Armistice Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-23,858
Closed -$228K – 207
2025
Q1 		$228K Sell
23,858
-144,216
-86% -$1.89M ﹤0.01% 197
2024
Q4 		$2.65M Sell
168,074
-185,926
-53% -$2.99M 0.04% 141
2024
Q3 		$5.36M Sell
354,000
-114,000
-24% -$1.74M 0.09% 120
2024
Q2 		$6.42M Buy
+468,000
New +$6.67M 0.08% 104
2022
Q2 		– Sell
-166,667
Closed -$4.12M – 179
2022
Q1 		$4.12M Hold
166,667
– – 0.08% 86
2021
Q4 		$4.66M Sell
166,667
-17,333
-9% -$568K 0.08% 110
2021
Q3 		$7.68M Sell
184,000
-1,333
-0.7% -$55.9K 0.13% 95
2021
Q2 		$8.63M Sell
185,333
-1,000
-0.5% -$49.5K 0.15% 90
2021
Q1 		$10.3M Sell
186,333
-32,334
-15% -$2.14M 0.24% 74
2020
Q4 		$15.9M Buy
218,667
+154,667
+242% +$18.1M 0.54% 55
2020
Q3 		$12.6M Buy
64,000
+14,333
+29% +$3.61M 0.46% 58
2020
Q2 		$13.9M Sell
49,667
-10,666
-18% -$2.49M 0.61% 56
2020
Q1 		$10.7M Sell
60,333
-36,000
-37% -$7.72M 0.66% 49
2019
Q4 		$23.7M Sell
96,333
-109,334
-53% -$20.1M 1.36% 24
2019
Q3 		$24.3M Buy
205,667
+39,000
+23% +$5.9M 1.61% 23
2019
Q2 		$27M Buy
166,667
+72,667
+77% +$13.8M 1.7% 18
2019
Q1 		$22.2M Buy
94,000
+85,667
+1,028% +$21.7M 1.22% 26
2018
Q4 		$2.26M Buy
+8,333
New +$2.41M 0.17% 55
2018
Q2 		– Sell
-10,667
Closed -$6.29M – 74
2018
Q1 		$6.29M Buy
10,667
+1,334
+14% +$827K 0.48% 51
2017
Q4 		$5.07M Buy
+9,333
New +$4.22M 0.51% 51

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
Monimus Capital Management Woodbridge, New Jersey $361M AUM 21.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Armistice Capital's ASMB Position: Q2 2025 in Review

Armistice Capital sold out of Assembly Biosciences (ASMB) in Q2 2025, closing a stake of 23,858 shares — an estimated $228K sold.

Armistice Capital first reported a position in ASMB in Q4 2017 and held it in 20 quarters. The position peaked at $27M in Q2 2019. 33 funds tracked by Wall St. Rank hold ASMB as of Q2 2025.

  • Armistice Capital reported no remaining Assembly Biosciences position as of Q2 2025 after selling out during the quarter.
  • Armistice Capital sold 23,858 Assembly Biosciences shares in Q2 2025, an estimated $228K.
  • Armistice Capital first reported a position in Assembly Biosciences in Q4 2017 and held it in 20 quarters.
  • Armistice Capital's Assembly Biosciences position peaked at $27M in Q2 2019.
  • 33 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.